Balancing Inpatient and Outpatient Oncology Care
Search for other papers by Rachel McDevitt in
Current site
Google Scholar
PubMed
Search for other papers by John McLean in
Current site
Google Scholar
PubMed
Search for other papers by Mikaela Olsen in
Current site
Google Scholar
PubMed
Search for other papers by Beth Souza in
Current site
Google Scholar
PubMed
Search for other papers by Anna Halpern in
Current site
Google Scholar
PubMed
The trend of moving oncology care to the outpatient setting is driven by clinical and patient-centered aspects, financial benefits, and the lack of inpatient bed space. At the NCCN 2024 Annual Conference, a panel of experts discussed challenges and opportunities in providing high-quality outpatient oncology care, including resource allocation, leadership recognition, and involving all stakeholders in the decision-making process. Speakers also highlighted the difficulties in providing adequate outpatient cancer care, such as limited lodging options, adapting treatment for elderly patients, and managing infection risk. Strategies for improving patient satisfaction, reducing costs, and enhancing quality of care centered on proactive risk assessment, standardization of policies and procedures, and creative solutions such as curbside clinics.
Disclosures: Dr. Olsen has disclosed receiving honoraria from BD; and serving as a consultant for BD. Dr. Halpern has disclosed receiving grant/research support from Bayer HealthCare, Disc Medicine, Gilead Sciences, Inc., Incyte Corporation, Jazz Pharmaceuticals, Karyopharm Therapeutics, Merck & Co., Inc., PharmEssentia USA, and Protagonist Therapeutics Inc.; serving as a consultant for AbbVie, Inc., Karyopharm Therapeutics, and Notable Labs; receiving trial funding from PharmEssentia USA; and receiving honoraria from Curio Sciences. The remaining presenters have disclosed no relevant financial relationships.
© 2019-2024 National Comprehensive Cancer Network